Clinical Trials Browser

Phase 1 × Advanced Solid Tumors × mogamulizumab × Clear all

NCT02301130 2024-04-25

Study of Mogamulizumab + MEDI4736 (Durvalumab) and Mogamulizumab + Tremelimumab in Subjects w/ Advanced Solid Tumors

Phase 1 Completed

Other solid neoplasm

Advanced Solid Tumors